期刊文献+

异基因造血干细胞移植后100d内腹泻病因分析 被引量:6

Etiology of diarrhea after allogeneic haemopoietic stem cell transplantation:a retrospective study
原文传递
导出
摘要 目的回顾性分析异基因造血干细胞移植(Allo-HSCT)后100d内腹泻的临床特点及病因谱。方法总结北京大学人民医院2006年9月至2007年3月125例Allo-HSCT患者移植后100d内的资料。结果76例发生移植后腹泻的患者累计发病114例次,总发生率60.8%(76/125)。病因分析显示,预处理毒性62例次(54.4%),急性移植物抗宿主病(aGVHD)32例次(28.1%),感染性腹泻15例次(13.2%),血栓性微血管病(TMA)及植入综合征各2例次,治疗相关性腹泻1例次。76例移植后腹泻治愈72例,死亡4例(5.3%)。Cox回归分析显示,HLA配型不合(R=6.643,P=0.026)及高危疾病状态(R=3.749,P=0.001)是腹泻发生的危险因素。结论腹泻是Allo-HSCT后的常见症状,其病因包括感染和非感染因素,针对病因的治疗可以改善预后。 Objective To retrospectively analyze the etiology and clinical features of diarrhea post allogeneic haemopoietic stem cell transplantation (allo-HSCT). Methods Analysis was made of 125 allo-HSCT recipients in Pekin university people's hospital during Sep 2006 to Mar 2007. Results 114 episodes of diarrhea occurred in 76 patients with the morbidity of 60. 8% ( 76/125 ). 62 epsiodes ( 54. 4% ) were caused by conditioning regimen ; 32 episodes ( 28. 1% ) were caused by intestinal acute graft-versus-host disease (aGVHD) ;15 episodes (13.2%) were caused by intestinal infection;2 episodes were caused by thrombotic mieroangiopathy (TMA) and engraftment syndrome respectively;in addition, 1 episode was caused by treatment. 72 patients with episodes of diarrhea were cured and 4 patients (5.3%) died. HLA mismatching (R = 6. 643 ,P = 0. 026 ) and patients with high risk (R = 3. 749 ,P = 0. 001 ) were determined to be risk factors for episodes of diarrhea by cox regression analysis. Conclusion Diarrhea is common symptom in allo-HSCT recipients, of which etiology includes infection and non-infection. Its clinical outcome could be improved by specific therapy.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第7期622-625,共4页 Chinese Journal of Practical Internal Medicine
关键词 腹泻 异基因造血干细胞移植 急性移植物抗宿主病 diarrhea allogeneic haemopoiefic stem cell transplantation acute graft-versus-host disease
  • 相关文献

参考文献9

  • 1Gagandeep K, Alok S, Anna BP, et al. Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India[ J]. Transplantation ,2002,73 : 1247 - 1251.
  • 2Baker CC, Anderson RA, RS Sauve, et al. GI complications in pediatric patients post-BMT[ J]. BMT,2005,36:51 - 58.
  • 3Huang X J, Lu DP, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies [ J ]. BMT, 2006, 38 : 291 - 297.
  • 4唐承薇.内科学[M].6版.北京:人民卫生出版社,2006:425-429.
  • 5Miller AB, Hoogstratem B, Staquet M, et al. Reparting results of cancer treatment[J].Cancer, 1981,47:207 - 214.
  • 6Tomas ED, Storb R, Clift RA, et al. Bone marrow transplantation [ J]. N Engl J ned, 1975,292:895.
  • 7Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation [ J ]. BMT,2001,27 :893 - 897.
  • 8Daly AS, Xenocostas A, Lipton JH. Transplantation-associated thrombotic microangiopathy: twenty-tow years later [ J ]. BMT, 2002,30:709 -715.
  • 9Holler E,Kolb HJ,Mittermuller J,et al. Modulation of acute graftversus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor-or release in the course of pretransplant conditioning:role of conditioning regimens andprop hylactic application of a monoclonal antibody neutralizing human TNF-α [ J ]. Blood. 1995.86 : 890 - 899.

同被引文献46

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部